AetherAI
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 1.3m | 3.3m | 4.5m | 4.9m | 6.6m |
% growth | - | 158 % | 36 % | 9 % | 35 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | - | ||
$1.1m | Seed | ||
$6.0m | Series A | ||
Total Funding | AUD11.0m |
Recent News about AetherAI
EditAetherAI, founded in 2015, specializes in AI-powered digital pathology solutions. The company focuses on developing intuitive web interfaces for medical images and AI-powered image analysis. AetherAI serves healthcare providers, research institutions, and medical professionals, primarily in the medical imaging and pathology sectors. The business model revolves around providing a comprehensive platform that integrates multi-modality image viewers, annotation tools, and deep learning frameworks. This platform enables expert-level cancer screening and prognosis prediction models, which are ready for clinical trials. AetherAI generates revenue through subscription fees, licensing its technology, and offering customized solutions for large-scale research and development collaborations. The company operates in the global healthcare market, aiming to revolutionize medical imaging and diagnostics through artificial intelligence.
Keywords: AI-powered, digital pathology, cancer screening, prognosis prediction, medical imaging, web interface, deep learning, healthcare, research collaboration, intuitive platform.